Perioperative substance P/NK1R pharmacology: from PONV control to a testable cancer neuro-immune hypothesis - Poll - MDSpire

Perioperative substance P/NK1R pharmacology: from PONV control to a testable cancer neuro-immune hypothesis

  • By

  • Jing Zhao

  • Zhongwei Liu

  • Jun Wang

  • July 16, 2026

Share

Original Source(s)

Perioperative substance P/NK1R pharmacology: from PONV control to a testable cancer neuro-immune hypothesis

  • by Jing Zhao, Zhongwei Liu, Jun Wang

  • July 16, 2026

Related Content

Immune checkpoint crosstalk: CTLA-4/CD80 engagement as a predictor of anti-PD-1/PD-L1 therapy outcome in NSCLC

Financial distress among women with advanced or metastatic breast cancer in Germany: secondary analysis of prospective ePROCOM data of a two-center cohort

Quantitative assessment of inter-observer consistency in target volume delineation following breast-conserving surgery and mastectomy